Savara (SVRA) Change in Acquisitions & Divestments (2018 - 2026)

Savara's (SVRA) quarterly Change in Acquisitions & Divestments came in at $13.1 million in Q1 2026, down 70.42% year-on-year from $44.4 million in Q1 2025, and up 108.84% on a QoQ basis from -$148.5 million in Q4 2025.

Savara (SVRA) Change in Acquisitions & Divestments (2018 - 2026) Analysis & Trends

Savara (SVRA) has 9 years of Change in Acquisitions & Divestments data on file, last reported at $13.1 million in Q1 2026.

  • On a quarterly basis, Change in Acquisitions & Divestments fell 70.42% year-over-year to $13.1 million in Q1 2026; TTM through Mar 2026 was -$27.0 million, a 116.07% decrease from a year earlier, with the FY2025 full-year figure at $4.3 million, down 97.41% from the prior year.
  • Change in Acquisitions & Divestments for Q1 2026 stood at $13.1 million, up from -$148.5 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for SVRA reached as high as $119.5 million in Q4 2022 and fell as low as -$148.5 million in Q4 2025.
  • Historically, Change in Acquisitions & Divestments has averaged $30.0 million across 5 years, with a median of $40.6 million in 2024.
  • Across the five-year window, Change in Acquisitions & Divestments soared 300.3% in 2022 and plunged 397.34% in 2025, its largest moves.
  • Year by year, Change in Acquisitions & Divestments stood at $119.5 million in 2022, then plunged by 62.01% to $45.4 million in 2023, then gained by 10.02% to $49.9 million in 2024, then plunged by 397.34% to -$148.5 million in 2025, then surged by 108.84% to $13.1 million in 2026.
  • Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $13.1 million in Q1 2026, -$148.5 million in Q4 2025, and $44.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Savara 1.39 Bn 1.39 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 13.13 Mn
Mar 31, 2026 13.13 Mn
Dec 31, 2025 -148.52 Mn
Dec 31, 2025 -148.52 Mn
Sep 30, 2025 44.40 Mn
Sep 30, 2025 44.40 Mn
Jun 30, 2025 64.00 Mn
Jun 30, 2025 64.00 Mn
Mar 31, 2025 44.40 Mn
Mar 31, 2025 44.40 Mn
Dec 31, 2024 49.95 Mn
Dec 31, 2024 49.95 Mn
Sep 30, 2024 40.55 Mn
Sep 30, 2024 40.55 Mn
Jun 30, 2024 33.00 Mn
Jun 30, 2024 33.00 Mn
Mar 31, 2024 41.50 Mn
Mar 31, 2024 41.50 Mn
Dec 31, 2023 45.40 Mn
Dec 31, 2023 45.40 Mn